Aignosis is a Jaipur-based Indian healthtech company that builds AI-assisted screening for autism and developmental delays in children aged 16 months to nine years. Its system uses a standard laptop and webcam to record a short video of the child responding to nine stimulus modules, with computer vision analysing behavioural signals such as eye gaze and response to name to produce a risk report indicating whether formal clinical assessment is warranted - a screening layer, not a diagnosis. It operates a clinic-in-clinic model that equips paediatricians to embed developmental screening in their practices, and its screening technology is CDSCO Class B certified.
1
Round
1
Industry
4
Tags
Oct 1, 2026
Latest raise
Funding activity · 1 round
Oct 1, 2026
INR 40M
Seed
Led by Antler
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
